pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3120 |
Genomic Coordinates | chr1: 172138808 - 172138888 |
Description | Homo sapiens miR-3120 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3120-5p | |||||||||||||||||||||
Sequence | 13| CCUGUCUGUGCCUGCUGUACA |33 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||
Editing Events in miRNAs |
|
DRVs in miRNA |
|
|||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ACVR1B | ||||||||||||||||||||
Synonyms | ACTRIB, ACVRLK4, ALK4, SKR2 | ||||||||||||||||||||
Description | activin A receptor type 1B | ||||||||||||||||||||
Transcript | NM_004302 | ||||||||||||||||||||
Other Transcripts | NM_020327 , NM_020328 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ACVR1B | |||||||||||||||||||||
3'UTR of ACVR1B (miRNA target sites are highlighted) |
>ACVR1B|NM_004302|3'UTR 1 CTGCTCCCTCTCTCCACACGGAGCTCCTGGCAGCGAGAACTACGCACAGCTGCCGCGTTGAGCGTACGATGGAGGCCTAC 81 CTCTCGTTTCTGCCCAGCCCTCTGTGGCCAGGAGCCCTGGCCCGCAAGAGGGACAGAGCCCGGGAGAGACTCGCTCACTC 161 CCATGTTGGGTTTGAGACAGACACCTTTTCTATTTACCTCCTAATGGCATGGAGACTCTGAGAGCGAATTGTGTGGAGAA 241 CTCAGTGCCACACCTCGAACTGGTTGTAGTGGGAAGTCCCGCGAAACCCGGTGCATCTGGCACGTGGCCAGGAGCCATGA 321 CAGGGGCGCTTGGGAGGGGCCGGAGGAACCGAGGTGTTGCCAGTGCTAAGCTGCCCTGAGGGTTTCCTTCGGGGACCAGC 401 CCACAGCACACCAAGGTGGCCCGGAAGAACCAGAAGTGCAGCCCCTCTCACAGGCAGCTCTGAGCCGCGCTTTCCCCTCC 481 TCCCTGGGATGGACGCTGCCGGGAGACTGCCAGTGGAGACGGAATCTGCCGCTTTGTCTGTCCAGCCGTGTGTGCATGTG 561 CCGAGGTGCGTCCCCCGTTGTGCCTGGTTCGTGCCATGCCCTTACACGTGCGTGTGAGTGTGTGTGTGTGTCTGTAGGTG 641 CGCACTTACCTGCTTGAGCTTTCTGTGCATGTGCAGGTCGGGGGTGTGGTCGTCATGCTGTCCGTGCTTGCTGGTGCCTC 721 TTTTCAGTAGTGAGCAGCATCTAGTTTCCCTGGTGCCCTTCCCTGGAGGTCTCTCCCTCCCCCAGAGCCCCTCATGCCAC 801 AGTGGTACTCTGTGTCTGGCAGGCTACTCTGCCCACCCCAGCATCAGCACAGCTCTCCTCCTCCATCTCAGACTGTGGAA 881 CCAAAGCTGGCCCAGTTGTCCATGACAAAAGAGGCTTTTGGGCCAAAATGTGAGGGTGGTGGGTGGGATGGGCAGGGAAG 961 GAATCCTGGTGGAAGTCTTGGGTGTTAGTGTCAGCCATGGGAAATGAGCCAGCCCAAGGGCATCATCCTCAGCAGCATCG 1041 AGGAAGGGCCGAGGAATGTGAAGCCAGATCTCGGGACTCAGATTGGAATGTTACATCTGTCTTTCATCTCCCAGATCCTG 1121 GAAACAGCAGTGTATATTTTTGGTGGTGGTGGGTTTGGGGTGGGGAAGGGAAGGGCGGGCAAGGAGTGGGGAGGGAGTCT 1201 GGGGTGGGAGGGAGGCATCTGCATGGGTCTTCTTTTACTGGACTGTCTGATCAGGGTGGAGGGAAGGTGAGAGGTTTGCA 1281 TCCACTTCAGGAGCCCTACTGAAGGGAACAGCCTGAGCCGAACATGTTATTTAACCTGAGTATAGTATTTAACGAAGCCT 1361 AGAAGCACGGCTGTGGGTGGTGATTTGGTCAGCATATCTTAGGTATATAATAACTTTGAAGCCATAACTTTTAACTGGAG 1441 TGGTTTGATTTCTTTTTTTAATTTTATTGGGAGGGTTTGGATTTTAACTTTTTTTAATGTTGTTAAATATTAAGTTTTTG 1521 TAAAAGGAAAACCATCTCTGTGATTACCTCTCAATCTATTTGTTTTTAAAGAAATCCCTAAAAAAAAAAATTATCCAATT 1601 GAACGCACATAGCTCAATCACACTGGAAATGTTTGTCCTTGCACCTGAGCCTGTTCCCACTCAGCAGTGAGAGTTCCTCT 1681 TTGCCCTGAGGCTCAGTCTCTCTCGTATTTTGTCCCCACCCCCAATTCCTTGAGTGGTTTTTGCTCTAGGGCCCTTTCTT 1761 GCACTGTCCAGCTGGTTGTACCCTCTCCAGGCATTTATTCAACAAATGTGGGTGAAGTGCCTGCTGGGTGCCAGGTGCTG 1841 GGAATACATCTGTGGACAAGACATGCTTGGGTCCTACTCCTGGAGCACTGTAAAAAGAGCTGATTCAAGTAAGTAGATGC 1921 CTGTTTTGAGACCAGAAGGTTTCATAATTGGTTCTACGACCCTTTTGAGCCTAGAATTATTGTTCTTATATAAGATCACT 2001 GAAGAAAGAGGAACCCCCACAACCCCCTCCACAAAGAGACCAGGGGCGGGTGATGAGACCTGGGGTTTAGAACCCCAGGT 2081 GAGACCTCAAATCACTGCATTCATTCTGAGCCCCCTTCCTGTCCCCAGGGGAGGTGTATTGTGTATGTAGCCTTAGAGCA 2161 TCTCTGCCTCCAACCCAGCAGTTCTCTGCCAAAGCTTGTGGAGGAGGGAGAGCCCTGTCCCTGCCCTCAGGCTCCCCAGT 2241 GCTCCTGGCCCTTCTATTTATTTGACTGATTATTGCTTCTTTCCTTGCATTAAAGGAGATCTTCCCCTAACCTTTGGGCC 2321 AATTTACTGGCCACTAATTTCGTTTAAATACCATTGTGTCATTGGGGGGACCGTCTTTACCCCTGCTGACCTCCCACCTA 2401 TCCGCCCTGCAGCAGAACCTTGGCGGTTTATAGGTAATGATGGAACTTAGACTCCTCTTCCCAGAGTCACAAGTAGCCTC 2481 TGGGATCTGCCAACACACGTCCACTCCCAAGCCACTAGCCCACTCCCCAGTTGGCCCTTCTGCCCTTACCCCACACACAG 2561 TCCAACTCTTCCACCTCTGGGGAAGATGGAGCAGGTCTTTGGGAAGCTCCCACACCCACCTCTGCCACTCTTAACACTAA 2641 GTGAGAGTTGGGGAGAAACTGAAGCCGTGTTTTTGGCCCCCCGAGGCTAACCCTGATCCATAGTGCTACCTGCACCTCTG 2721 GATTCTGGATTCACAGACCAAGTCCAAGCCCGTTCTTACGTCGCCATAAAGGCCCCCGAACGGCATTCTCGGTACTTCTG 2801 TTTGTTTTTGTACATTTTATTAGAAAGGACTGTAAAATAGCCACTTAGACACTTTACCTCTTCAGTATGCAAATGTAAAT 2881 AAATTGTAATATAGGAAATCTTTTGTTTTAATATAAGAATGAGCCTGTCCAATTTCTGCTGTACATTATTAAAAGTTTTA 2961 TTCACAGAG Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 91.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset GSM4903825 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID14_NS |
Location of target site | NM_004302 | 3UTR | ACAGACACCUUUUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000257963.4 | 3UTR | ACAGACACCUUUUCUAUUUACCUCCUAAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000257963.4 | 3UTR | ACACCUUUUCUAUUUACCUCCUAAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
134 hsa-miR-3120-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT096972 | BDP1 | B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB | 2 | 2 | ||||||||
MIRT442624 | LOX | lysyl oxidase | 2 | 2 | ||||||||
MIRT473438 | MDM4 | MDM4, p53 regulator | 2 | 2 | ||||||||
MIRT490011 | KIFC2 | kinesin family member C2 | 2 | 2 | ||||||||
MIRT496449 | N6AMT1 | N-6 adenine-specific DNA methyltransferase 1 | 2 | 2 | ||||||||
MIRT496752 | TGIF2 | TGFB induced factor homeobox 2 | 2 | 2 | ||||||||
MIRT497721 | CYP1A1 | cytochrome P450 family 1 subfamily A member 1 | 2 | 2 | ||||||||
MIRT498287 | PADI3 | peptidyl arginine deiminase 3 | 2 | 2 | ||||||||
MIRT503195 | ACVR1B | activin A receptor type 1B | 2 | 4 | ||||||||
MIRT504760 | TEP1 | telomerase associated protein 1 | 2 | 4 | ||||||||
MIRT517810 | UGDH | UDP-glucose 6-dehydrogenase | 2 | 6 | ||||||||
MIRT519686 | ZNF622 | zinc finger protein 622 | 2 | 4 | ||||||||
MIRT520263 | URGCP | upregulator of cell proliferation | 2 | 2 | ||||||||
MIRT523051 | ICMT | isoprenylcysteine carboxyl methyltransferase | 2 | 2 | ||||||||
MIRT525601 | OLR1 | oxidized low density lipoprotein receptor 1 | 2 | 4 | ||||||||
MIRT526995 | ARL8B | ADP ribosylation factor like GTPase 8B | 2 | 2 | ||||||||
MIRT528699 | TRAF3IP2 | TRAF3 interacting protein 2 | 2 | 4 | ||||||||
MIRT533142 | WNT10A | Wnt family member 10A | 2 | 2 | ||||||||
MIRT537618 | ERI1 | exoribonuclease 1 | 2 | 2 | ||||||||
MIRT539707 | EIF3H | eukaryotic translation initiation factor 3 subunit H | 2 | 2 | ||||||||
MIRT539752 | CNBP | CCHC-type zinc finger nucleic acid binding protein | 2 | 2 | ||||||||
MIRT539808 | GAPVD1 | GTPase activating protein and VPS9 domains 1 | 2 | 2 | ||||||||
MIRT539941 | IFNAR2 | interferon alpha and beta receptor subunit 2 | 2 | 2 | ||||||||
MIRT540424 | FAM83F | family with sequence similarity 83 member F | 2 | 2 | ||||||||
MIRT540509 | CXCL10 | C-X-C motif chemokine ligand 10 | 2 | 2 | ||||||||
MIRT540720 | GUF1 | GUF1 homolog, GTPase | 2 | 2 | ||||||||
MIRT541630 | PARP2 | poly(ADP-ribose) polymerase 2 | 2 | 2 | ||||||||
MIRT542286 | POLR3K | RNA polymerase III subunit K | 2 | 2 | ||||||||
MIRT542456 | AKR7A2 | aldo-keto reductase family 7 member A2 | 2 | 2 | ||||||||
MIRT542550 | MRPS10 | mitochondrial ribosomal protein S10 | 2 | 2 | ||||||||
MIRT542771 | PPAP2B | phospholipid phosphatase 3 | 2 | 2 | ||||||||
MIRT550085 | TRAPPC2 | trafficking protein particle complex 2 | 2 | 2 | ||||||||
MIRT551458 | CARKD | NAD(P)HX dehydratase | 2 | 2 | ||||||||
MIRT555622 | PHLPP2 | PH domain and leucine rich repeat protein phosphatase 2 | 2 | 2 | ||||||||
MIRT569136 | KATNAL1 | katanin catalytic subunit A1 like 1 | 2 | 2 | ||||||||
MIRT572328 | HSPB6 | heat shock protein family B (small) member 6 | 2 | 2 | ||||||||
MIRT574607 | LZIC | leucine zipper and CTNNBIP1 domain containing | 2 | 2 | ||||||||
MIRT575583 | Mcm8 | minichromosome maintenance 8 homologous recombination repair factor | 2 | 4 | ||||||||
MIRT576125 | Hrk | harakiri, BCL2 interacting protein (contains only BH3 domain) | 2 | 5 | ||||||||
MIRT576657 | Fam216a | family with sequence similarity 216, member A | 2 | 2 | ||||||||
MIRT607222 | ACSM2A | acyl-CoA synthetase medium chain family member 2A | 2 | 4 | ||||||||
MIRT607292 | CD300E | CD300e molecule | 2 | 6 | ||||||||
MIRT607746 | ANGPT4 | angiopoietin 4 | 2 | 2 | ||||||||
MIRT607905 | SPRYD4 | SPRY domain containing 4 | 2 | 2 | ||||||||
MIRT608159 | HRK | harakiri, BCL2 interacting protein | 2 | 7 | ||||||||
MIRT608657 | ABCF3 | ATP binding cassette subfamily F member 3 | 2 | 4 | ||||||||
MIRT609115 | ZNF703 | zinc finger protein 703 | 2 | 6 | ||||||||
MIRT610231 | ACOT9 | acyl-CoA thioesterase 9 | 2 | 2 | ||||||||
MIRT610870 | NUDCD3 | NudC domain containing 3 | 2 | 2 | ||||||||
MIRT611217 | MC2R | melanocortin 2 receptor | 2 | 2 | ||||||||
MIRT614858 | PLEKHA6 | pleckstrin homology domain containing A6 | 2 | 2 | ||||||||
MIRT616966 | LMX1A | LIM homeobox transcription factor 1 alpha | 2 | 2 | ||||||||
MIRT617258 | GLIPR1L2 | GLI pathogenesis related 1 like 2 | 2 | 2 | ||||||||
MIRT618009 | SLC9A3R2 | SLC9A3 regulator 2 | 2 | 2 | ||||||||
MIRT619067 | BSND | barttin CLCNK type accessory beta subunit | 2 | 4 | ||||||||
MIRT619295 | FAM26E | calcium homeostasis modulator family member 5 | 2 | 2 | ||||||||
MIRT619348 | GINM1 | glycoprotein integral membrane 1 | 2 | 2 | ||||||||
MIRT619362 | CFHR5 | complement factor H related 5 | 2 | 2 | ||||||||
MIRT619541 | PIWIL2 | piwi like RNA-mediated gene silencing 2 | 2 | 2 | ||||||||
MIRT619782 | NRIP2 | nuclear receptor interacting protein 2 | 2 | 2 | ||||||||
MIRT619994 | NPAP1 | nuclear pore associated protein 1 | 2 | 2 | ||||||||
MIRT621030 | CDC14B | cell division cycle 14B | 2 | 2 | ||||||||
MIRT622033 | STAT5A | signal transducer and activator of transcription 5A | 2 | 2 | ||||||||
MIRT622728 | PITPNM3 | PITPNM family member 3 | 2 | 2 | ||||||||
MIRT623144 | NAV2 | neuron navigator 2 | 2 | 2 | ||||||||
MIRT623600 | IPO9 | importin 9 | 2 | 2 | ||||||||
MIRT624608 | B3GALT5 | beta-1,3-galactosyltransferase 5 | 2 | 2 | ||||||||
MIRT624905 | CTCFL | CCCTC-binding factor like | 2 | 2 | ||||||||
MIRT625030 | SPC24 | SPC24, NDC80 kinetochore complex component | 2 | 2 | ||||||||
MIRT625688 | MCM8 | minichromosome maintenance 8 homologous recombination repair factor | 2 | 5 | ||||||||
MIRT626531 | EMCN | endomucin | 2 | 2 | ||||||||
MIRT627204 | ZDHHC20 | zinc finger DHHC-type containing 20 | 2 | 2 | ||||||||
MIRT628033 | LSAMP | limbic system-associated membrane protein | 2 | 2 | ||||||||
MIRT628203 | FREM2 | FRAS1 related extracellular matrix protein 2 | 2 | 2 | ||||||||
MIRT631012 | LINS | lines homolog 1 | 2 | 2 | ||||||||
MIRT633195 | HSPE1-MOB4 | HSPE1-MOB4 readthrough | 2 | 2 | ||||||||
MIRT633890 | CACNG8 | calcium voltage-gated channel auxiliary subunit gamma 8 | 2 | 2 | ||||||||
MIRT634023 | MOB4 | MOB family member 4, phocein | 2 | 2 | ||||||||
MIRT634416 | PLCXD3 | phosphatidylinositol specific phospholipase C X domain containing 3 | 2 | 2 | ||||||||
MIRT636866 | ARSE | arylsulfatase E (chondrodysplasia punctata 1) | 2 | 2 | ||||||||
MIRT642527 | ANKRD9 | ankyrin repeat domain 9 | 2 | 2 | ||||||||
MIRT645408 | FAM110A | family with sequence similarity 110 member A | 2 | 2 | ||||||||
MIRT645635 | SYTL4 | synaptotagmin like 4 | 2 | 2 | ||||||||
MIRT646013 | TNFAIP8L2 | TNF alpha induced protein 8 like 2 | 2 | 2 | ||||||||
MIRT646686 | ASGR2 | asialoglycoprotein receptor 2 | 2 | 2 | ||||||||
MIRT652838 | TACO1 | translational activator of cytochrome c oxidase I | 2 | 2 | ||||||||
MIRT655156 | PHF21B | PHD finger protein 21B | 2 | 2 | ||||||||
MIRT658491 | EXOC7 | exocyst complex component 7 | 2 | 2 | ||||||||
MIRT659398 | CORO2A | coronin 2A | 2 | 2 | ||||||||
MIRT666825 | PRCP | prolylcarboxypeptidase | 2 | 2 | ||||||||
MIRT666866 | POU2F2 | POU class 2 homeobox 2 | 2 | 2 | ||||||||
MIRT668224 | GABRA1 | gamma-aminobutyric acid type A receptor alpha1 subunit | 2 | 2 | ||||||||
MIRT673288 | PDE3A | phosphodiesterase 3A | 2 | 2 | ||||||||
MIRT673878 | KLF2 | Kruppel like factor 2 | 2 | 2 | ||||||||
MIRT681721 | KCNE4 | potassium voltage-gated channel subfamily E regulatory subunit 4 | 2 | 2 | ||||||||
MIRT682406 | PARD6B | par-6 family cell polarity regulator beta | 2 | 2 | ||||||||
MIRT684109 | MCM10 | minichromosome maintenance 10 replication initiation factor | 2 | 2 | ||||||||
MIRT684423 | TUFT1 | tuftelin 1 | 2 | 2 | ||||||||
MIRT684684 | OR7D2 | olfactory receptor family 7 subfamily D member 2 | 2 | 2 | ||||||||
MIRT686638 | TMEM184C | transmembrane protein 184C | 2 | 2 | ||||||||
MIRT689457 | NXN | nucleoredoxin | 2 | 2 | ||||||||
MIRT689627 | NAA30 | N(alpha)-acetyltransferase 30, NatC catalytic subunit | 2 | 2 | ||||||||
MIRT690773 | PLA2G2C | phospholipase A2 group IIC | 2 | 2 | ||||||||
MIRT690822 | SGSM2 | small G protein signaling modulator 2 | 2 | 2 | ||||||||
MIRT693669 | MXRA7 | matrix remodeling associated 7 | 2 | 2 | ||||||||
MIRT695553 | CLPB | ClpB homolog, mitochondrial AAA ATPase chaperonin | 2 | 2 | ||||||||
MIRT695872 | C19orf52 | translocase of inner mitochondrial membrane 29 | 2 | 2 | ||||||||
MIRT698160 | TNFRSF13C | TNF receptor superfamily member 13C | 2 | 2 | ||||||||
MIRT699933 | RUFY2 | RUN and FYVE domain containing 2 | 2 | 2 | ||||||||
MIRT708639 | UBE2W | ubiquitin conjugating enzyme E2 W | 2 | 2 | ||||||||
MIRT710816 | RAB11FIP4 | RAB11 family interacting protein 4 | 2 | 2 | ||||||||
MIRT711242 | TRAT1 | T-cell receptor associated transmembrane adaptor 1 | 2 | 2 | ||||||||
MIRT711542 | MSH3 | mutS homolog 3 | 2 | 2 | ||||||||
MIRT711749 | DTX1 | deltex E3 ubiquitin ligase 1 | 2 | 2 | ||||||||
MIRT712303 | PGM2L1 | phosphoglucomutase 2 like 1 | 2 | 2 | ||||||||
MIRT712922 | RPF2 | ribosome production factor 2 homolog | 2 | 2 | ||||||||
MIRT714027 | SYDE2 | synapse defective Rho GTPase homolog 2 | 2 | 2 | ||||||||
MIRT714768 | TERF1 | telomeric repeat binding factor 1 | 2 | 2 | ||||||||
MIRT714844 | ADAMTS17 | ADAM metallopeptidase with thrombospondin type 1 motif 17 | 2 | 2 | ||||||||
MIRT715223 | NPVF | neuropeptide VF precursor | 2 | 2 | ||||||||
MIRT716110 | GMPS | guanine monophosphate synthase | 2 | 2 | ||||||||
MIRT716174 | FAM71F2 | family with sequence similarity 71 member F2 | 2 | 2 | ||||||||
MIRT716383 | C6orf223 | chromosome 6 open reading frame 223 | 2 | 2 | ||||||||
MIRT716527 | KSR2 | kinase suppressor of ras 2 | 2 | 2 | ||||||||
MIRT716962 | P2RY6 | pyrimidinergic receptor P2Y6 | 2 | 2 | ||||||||
MIRT717605 | DSTYK | dual serine/threonine and tyrosine protein kinase | 2 | 2 | ||||||||
MIRT717696 | PTGS1 | prostaglandin-endoperoxide synthase 1 | 2 | 2 | ||||||||
MIRT721360 | ENTHD1 | ENTH domain containing 1 | 2 | 2 | ||||||||
MIRT721381 | MACC1 | MACC1, MET transcriptional regulator | 2 | 2 | ||||||||
MIRT721935 | RASSF2 | Ras association domain family member 2 | 2 | 2 | ||||||||
MIRT722094 | SUSD1 | sushi domain containing 1 | 2 | 2 | ||||||||
MIRT722837 | C17orf102 | chromosome 17 open reading frame 102 | 2 | 2 | ||||||||
MIRT722990 | TOR1A | torsin family 1 member A | 2 | 2 | ||||||||
MIRT724174 | ABCF2 | ATP binding cassette subfamily F member 2 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|